Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04673981
Other study ID # RBHP 2020 PHAM DANG
Secondary ID 2020-A00476-33
Status Recruiting
Phase N/A
First received
Last updated
Start date July 31, 2020
Est. completion date July 2025

Study information

Verified date September 2020
Source University Hospital, Clermont-Ferrand
Contact Lise LACLAUTRE
Phone +33473754963
Email promo_interne_drci@chu-clermontferrand.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Following preliminary studies carried out in our department on these subject and subjective findings during clinical examinations, it has been shown that pain is a symptom that is rarely reported following treatment. Instead, neurosensory disorders such as hypoesthesia and paresthesia are found. The objective of the study is to map and qualitatively evaluate neurosensory disorders in patients treated for cancers of the oral cavity and oropharynx.


Description:

The protocol, which is done during the usual follow-up consultation of the patient by the maxillo-facial surgeon, is divided into 3 parts: PART 1: Collection of Data and Consent - Patient Data: - Date of visit and inclusion in the study - Patient initials - Age - Gender (male or female) - The weight - The size - Verification of inclusion and non-inclusion criteria: - General patient history: - Patient history - Ongoing Treatments - Professional activity - Tumor: - Features - Location - TNM - Histological type - Search for risk factors for peripheral neuropathy - Check for symptoms of peripheral neuropathy. PART 2: Collecting Treatment Data - Operating data: - Operation date - Type of surgery - Duration of surgery - Severed sensory nerves - Perioperative complications - On the way out: - Adjuvant treatment including radiotherapy and/or chemotherapy. - Exit analgesic treatment - EN (Numerical Scale) PART 3: Collection of data related to neurosensory disorders and pain - Analgesics consumed - Questionnaire DN4 for each operated area separated according to the curage, lumpectomy and reconstruction if they take place. - If DN4 positive, completion of the QCD and QEDN questionnaires. - Clinical examination for sensory disturbances reported on a chart. - Generic quality of life questionnaire adapted to cancer pathology EORTC QLQC30 and its specific Head and Neck35 add-on module adapted to head and neck cancers. - Thermotest and hot water, cold water (for the oral cavity) - HADS Questionnaire - Catastrophe Questionnaire - Quantitative sensory testing (QST) for neuropathic patients : Mechanical neurosensory disorders will be tested with the Von frey filament and the brush. - Hypoesthesia or mechanical anaesthesia will be sought with the Von Frey filament and the brush. - Mechanical hypersensitivity, a painful sensation exacerbated by a sharp, non-traumatic object, will be sought with a large calibre Von Frey filament. - Static Allodynia, felt painful on contact, will be sought at Von Frey's filament. - Dynamic Allodynia, felt painful when rubbed, will be sought with a wide brush (8 mm) over a distance of several centimetres. Thermal neurosensory disorders will be sought for the skin with the Thermotest and at the level of the oral cavity with the application of standardised test tubes containing water at 4°C stored in the fridge or hot water at 63°C (the protocol consists of heating water at 4°C in the microwave for 30 seconds to obtain the temperature of 63°C); these examinations will allow the evaluation of thermal allodynia and hypoesthesia. The examination will cover the entire face, the oral cavity, the cervical region and the area where the reconstruction flaps are taken. The pathological areas identified will be delimited on diagrams previously made with a coding according to the sensations collected.


Recruitment information / eligibility

Status Recruiting
Enrollment 120
Est. completion date July 2025
Est. primary completion date July 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patient treated for an oral cavity and oropharynx tumor from at least one year and maximum five years. - Women or men upper 18 years old) - Patient with full consent, aware and signed - Patient cover by the French social security system Exclusion Criteria: - Patient with mental disorder, psychologic, with a defect of comprehension to agree fully the protocol - Pregnant women or nursing - Patients who can't comply with the protocol - Participation refusal - Inable full age patient or under judicial protection

Study Design


Intervention

Diagnostic Test:
diagnostic tes for neuropathic pain
Thermotest and hot water, cold water (for the oral cavity), Von frey filament and the brush

Locations

Country Name City State
France CHU de Clermont-Ferrand Clermont-Ferrand

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Clermont-Ferrand

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary hypoesthesia on surgical site using a brush and Von Frey Filament The measure is a binary measure (positive or negative) day 0
Primary anaesthesia on surgical site using a brush and Von Frey Filament The measure is a binary measure (positive or negative) day 0
Primary allodynia on surgical site The measure is a binary measure (positive or negative) by clinical examination day 0
Primary Evaluation of the characteristics of the pain by questionnaire DN4 One standard DN4 with four questions and ten pain characteristics which gave a score from zero to ten points. If DN4 equal or superior of four out of ten the patient seems possible to develop neuropathic pain. Day 0
Primary hyperalgesia on surgical site using a brush and Von Frey Filament The measure is a binary measure (positive or negative) Day 0
Primary Evaluation of the characteristics of the pain by questionnaire Neuropathic Pain Symptom Inventory (NPSI) Twelve questions with a score from zero to ten, zero stands for no pain and ten maximal pain scale. A score is given for burning pain (score out of ten), constriction pain (score out of ten), paroxystic pain (score out of ten), evoked pain (score out of ten), paresthesia (score out of ten) and a total score (out of one hundred) Day 0
Primary Evaluation of the characteristics of the pain by questionnaire Brief Pain Inventory Fifteen questions compose the questionnaire, the first one is a binary answer yes or no, the second one is a schema to localize the pain, thirteen following questions are scaled with a score from zero to ten, zero stands for no pain and ten maximal pain scale Day 0
Secondary Questionnaire EORTC QLQC30 to assess Quality of life of cancer patients a score is given for each question, Thirty questions with for each question a score from one (not at all), two (a bit), three (enough) to four (a lot). Two last questions are scale from one (really bad) to seven (excellent) day 0
Secondary Questionnaire EORTC QLQ-H&N35 to assess Quality of life of head and neck cancer patient a score is given for 34 questions (with for each question a score from one (not at all), two (a bit), three (enough) to four (a lot)), for the last 5 questions there is a binary scale (1 for no answer and 2 for yes). day 0
Secondary Quality of life evaluate by the Questionnaire EORTC QLQ-H&N35 a score is given for 34 questions (with for each question a score from one (not at all), two (a bit), three (enough) to four (a lot)), for the last 5 questions there is a binary scale (1 for no answer and 2 for yes) Day 0
Secondary Pain Catastrophizing Scale (PCS-CF) to assess the catastrophizing thirteen questions with for each question a score from zero (not at all), one (a bit), two (moderatly), three (a lot) to four (constantly).
A score inferior than thirty mark a moderate risk to develop chronic pain. A score superior than thirty mark a high risk to develop chronic pain.
Day 0
Secondary Anxious and depression disorder screening using questionnaire Hospital Anxiety and Depression scale (HAD) Fourteen items scaled from zero to three, seven questions refer to anxiety seven others to depressive dimension Both of them gathered to make a score of twenty-one for maximum day 0
See also
  Status Clinical Trial Phase
Completed NCT01659073 - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation N/A
Recruiting NCT05914311 - Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration N/A
Recruiting NCT05422456 - The Turkish Version of Functional Disability Inventory
Enrolling by invitation NCT05422443 - The Turkish Version of Pain Coping Questionnaire
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04385030 - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury N/A
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed NCT03687762 - Back on Track to Healthy Living Study N/A
Completed NCT04171336 - Animal-assisted Therapy for Children and Adolescents With Chronic Pain N/A
Completed NCT03179475 - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury Phase 4
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT06060028 - The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain N/A
Recruiting NCT06204627 - TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Terminated NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Not yet recruiting NCT05812703 - Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain